DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2004

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended

31/12/2004
Quarter4
Financial Year End31/12/2004
The figureshave not been audited

Attachments

DBIOTEC-Q4 2004 20050224.xls
110 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/12/2004 
31/12/2003 
31/12/2004 
31/12/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
21,104
15,994
79,140
73,833
2Profit/(loss) before tax
6,373
6,289
26,614
24,220
3Profit/(loss)
after tax and minority
interest
5,853
4,478
22,755
17,720
4Net profit/(loss) for
the period
5,853
4,478
22,755
17,720
5Basic earnings/(loss) per share (sen)
4.43
3.39
17.24
13.42
6Dividend per share (sen)
6.00
8.00
9.00
13.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

0.7800
1.4500

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
Please refer to Note B12 for further explanation on the total dividend payment.


Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced24 Feb 2005  
CategoryFinancial Results
Reference NoCS-050221-70975